Gilead Sciences's Revenue by Region
In fiscal year 2025, Gilead Sciences's revenue by geographical region are as follows:
- Europe: $5.06 B
- Other International: $3.50 B
- UNITED STATES: $20.88 B
Learn more about Gilead Sciences’s Revenue by Products
Check out competitors to Gilead Sciences in a side-by-side comparison.
Explore additional financial metrics for Gilead Sciences.
Gilead Sciences's Revenue Share by Region
| Americas | 23095000000 |
|---|---|
| Asia Pacific | 12804000000 |
| EMEA | 17819000000 |
| Europe | 4310000000 |
| Other International | 3368000000 |
| UNITED STATES | 19438000000 |
| Americas | 23251000000 |
|---|---|
| Asia Pacific | 12264000000 |
| EMEA | 18044000000 |
| Europe | 4634000000 |
| Other International | 3529000000 |
| UNITED STATES | 20591000000 |
| Europe | 5064000000 |
|---|---|
| Other International | 3503000000 |
| UNITED STATES | 20876000000 |
The above chart shows Gilead Sciences's revenue percentage share by geographical region.
In fiscal year 2023, Gilead Sciences's revenue by region is as follows:
- Americas generated $23.10 B in revenue, representing 28.57% of its total revenue.
- Asia Pacific generated $12.80 B in revenue, representing 15.84% of its total revenue.
- EMEA generated $17.82 B in revenue, representing 22.04% of its total revenue.
- Europe generated $4.31 B in revenue, representing 5.33% of its total revenue.
- Other International generated $3.37 B in revenue, representing 4.17% of its total revenue.
- UNITED STATES generated $19.44 B in revenue, representing 24.05% of its total revenue.
The biggest region for Gilead Sciences is the Americas, which represents 28.57% of its total revenue.
The smallest region for Gilead Sciences is the Other International, which represents 4.17% of its total revenue.
The above chart shows Gilead Sciences's revenue percentage share by geographical region.
In fiscal year 2024, Gilead Sciences's revenue by region is as follows:
- Americas generated $23.25 B in revenue, representing 28.25% of its total revenue.
- Asia Pacific generated $12.26 B in revenue, representing 14.9% of its total revenue.
- EMEA generated $18.04 B in revenue, representing 21.92% of its total revenue.
- Europe generated $4.63 B in revenue, representing 5.63% of its total revenue.
- Other International generated $3.53 B in revenue, representing 4.29% of its total revenue.
- UNITED STATES generated $20.59 B in revenue, representing 25.02% of its total revenue.
The biggest region for Gilead Sciences is the Americas, which represents 28.25% of its total revenue.
The smallest region for Gilead Sciences is the Other International, which represents 4.29% of its total revenue.
The above chart shows Gilead Sciences's revenue percentage share by geographical region.
In fiscal year 2025, Gilead Sciences's revenue by region is as follows:
- Europe generated $5.06 B in revenue, representing 17.2% of its total revenue.
- Other International generated $3.50 B in revenue, representing 11.9% of its total revenue.
- UNITED STATES generated $20.88 B in revenue, representing 70.9% of its total revenue.
The biggest region for Gilead Sciences is the UNITED STATES, which represents 70.9% of its total revenue.
The smallest region for Gilead Sciences is the Other International, which represents 11.9% of its total revenue.
Summary Table
| Geography (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Americas | 28.57% | 28.25% | 0% |
| Asia Pacific | 15.84% | 14.9% | 0% |
| EMEA | 22.04% | 21.92% | 0% |
| Europe | 5.33% | 5.63% | 17.2% |
| Other International | 4.17% | 4.29% | 11.9% |
| UNITED STATES | 24.05% | 25.02% | 70.9% |
| Total Revenue | 100% | 100% | 100% |
Gilead Sciences's Regions Revenue Trend
The above chart shows the revenue trend of different segments of Gilead Sciences.
In fiscal year 2025, the UNITED STATES generated the most revenue ($20.88 B), and the Other International generated the least revenue ($3.50 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Region | 2023 | 2024 | 2025 |
|---|---|---|---|
| Americas | $23.10 B - |
$23.25 B
0.68%
|
- - |
| Asia Pacific | $12.80 B - |
$12.26 B
4.22%
|
- - |
| EMEA | $17.82 B - |
$18.04 B
1.26%
|
- - |
| Europe | $4.31 B - |
$4.63 B
7.52%
|
$5.06 B
9.28%
|
| Other International | $3.37 B - |
$3.53 B
4.78%
|
$3.50 B
0.74%
|
| UNITED STATES | $19.44 B - |
$20.59 B
5.93%
|
$20.88 B
1.38%
|
| Total Revenue | $80.83 B - |
$82.31 B
1.83%
|
$29.44 B
64.23%
|
Related
-
Agilent Technologies Revenue by Region
-
Eli Lilly and Company Revenue by Region
-
Stryker Corporation Revenue by Region
-
Johnson & Johnson Revenue by Region
-
AbbVie Revenue by Region
-
Merck & Co. Revenue by Region
-
Thermo Fisher Scientific Revenue by Region
-
Abbott Laboratories Revenue by Region
-
Danaher Corporation Revenue by Region
-
Amgen Revenue by Region
